Cyclic ketone inhibitors of cathepsin K

被引：0
|
作者：
Tranter, D
机构：
来源：
DRUG DISCOVERY TODAY | 2001年 / 6卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：545 / 545
页数：1
相关论文
共 50 条
  • [41] Cathepsin K inhibitors: A novel target for osteoporosis therapy
    Stoch, S. A.
    Wagner, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (01) : 172 - 176
  • [42] Acyclic cyanamide-based inhibitors of cathepsin K
    Barrett, DG
    Deaton, DN
    Hassell, AM
    McFadyen, RB
    Miller, AB
    Miller, LR
    Payne, JA
    Shewchuk, LM
    Willard, DH
    Wright, LL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (12) : 3039 - 3043
  • [43] Bone effects of cathepsin K inhibitors in the growing rabbit
    Pennypacker, B.
    Rodan, S.
    Rodan, G.
    Black, C.
    Oballa, R.
    Wehren, L.
    Kimmel, D.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S117 - S118
  • [44] In Search of Selective Inhibitors of Cysteine Protease, Cathepsin K
    Ewa Wieczerzak
    Piotr Drabik
    Magnus Abrahamson
    Anders Grubb
    International Journal of Peptide Research and Therapeutics, 2005, 11 : 203 - 209
  • [45] Structure and design of potent and selective cathepsin K inhibitors
    Yamashita, DS
    Smith, WW
    Zhao, BG
    Janson, CA
    Tomaszek, TA
    Bossard, MJ
    Levy, MA
    Oh, HJ
    Carr, TJ
    Thompson, SK
    Ijames, CF
    Carr, SA
    McQueney, M
    DAlessio, KJ
    Amegadzie, BY
    Hanning, CR
    AbdelMeguid, S
    DesJarlais, RL
    Gleason, JG
    Veber, DF
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (46) : 11351 - 11352
  • [46] Lead optimization of cathepsin K inhibitors for the treatment of Osteoarthritis
    Ginnetti, Anthony T.
    Paone, Daniel, V
    Nanda, Kausik K.
    Li, Jing
    Busuek, Marina
    Johnson, Scott A.
    Lu, Jun
    Soisson, Stephen M.
    Robinson, Ronald
    Fisher, John
    Webber, Andrea
    Wesolowski, Gregg
    Ma, Bennett
    Le Duong
    Carroll, Steven
    Burgey, Christopher S.
    Stachel, Shawn J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 74
  • [47] Orally Bioavailable Cathepsin K Inhibitors with Pyrrolopyrimidine Scaffold
    Teno, Naoki
    Masuya, Keiichi
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (07) : 752 - 766
  • [48] The consequences of lysosomotropism on the design of selective cathepsin K inhibitors
    Black, W. Cameron
    Percival, M. David
    CHEMBIOCHEM, 2006, 7 (10) : 1525 - 1535
  • [49] Natural biflavones as novel inhibitors of cathepsin B and K
    Zeng, G. -Z.
    Pan, X. -L.
    Tan, N. -H.
    Xiong, J.
    Zhang, Y. M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2006, 41 (11) : 1247 - 1252
  • [50] Advances in the discovery of cathepsin K inhibitors on bone resorption
    Lu, Jun
    Wang, Maolin
    Wang, Ziyue
    Fu, Zhongqi
    Lu, Aiping
    Zhang, Ge
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2018, 33 (01) : 890 - 904
12345